Memphis Pharmaceutical and Chemical Industries reported net losses of EGP 11.9 million ($1.6 million) for the first seven months of FY14/15, against net earnings of EGP 3 million ($393 thousand) in the corresponding period of last year.

The company had posted net losses of EGP 9.98 million for the six-month period ending in December 2014, versus net earnings of EGP 2.3 million in the same period of 2013.